Prostate cancer vaccine - Antigen Express

Drug Profile

Prostate cancer vaccine - Antigen Express

Latest Information Update: 25 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Antigen Express
  • Class Cancer vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Prostate cancer

Most Recent Events

  • 26 Apr 2005 Preclinical data from a media release have been added to the Cancer pharmacodynamics section
  • 03 Dec 2003 Data presented at the 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer (iSBTc-2003) have been added to the Cancer pharmacodynamics section
  • 22 Oct 2003 Preclinical trials in Prostate cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top